The expression pattern of VISTA was compared, using the TCGA dataset, to the expression of three critical immune checkpoints (Tim-3, LAG-3, PD-1) known for being highly expressed in advanced versus low glioma grades22–24. This evidence concerns the gene PDCD1 and central nervous system cancer.